These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3380862)

  • 21. Evaluation of named binders in Rauwolfia vomitoria root tablets.
    Onunkwo GC
    Boll Chim Farm; 2000; 139(3):132-9. PubMed ID: 10961024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of binders on sulfamethoxazole tablets.
    Agrawal YK; Prakasam K
    J Pharm Sci; 1988 Oct; 77(10):885-8. PubMed ID: 3236233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The compression of granulates containing solid dispersions.
    Kinget R; Kemel R
    Pharmazie; 1985 Jul; 40(7):475-7. PubMed ID: 4048252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of binder properties, method of addition, powder type and operating conditions on fluid-bed melt granulation and resulting tablet properties.
    Abberger T
    Pharmazie; 2001 Dec; 56(12):949-52. PubMed ID: 11802658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Batch production of pharmaceutical granulations in a fluidized bed. II. Effects of various binders and their concentrations on granulations and compressed tablets.
    Davies WL; Gloor WT
    J Pharm Sci; 1972 Apr; 61(4):618-22. PubMed ID: 5014325
    [No Abstract]   [Full Text] [Related]  

  • 26. Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation.
    Sun W; Ni R; Zhang X; Li LC; Mao S
    Drug Dev Ind Pharm; 2015 Jun; 41(6):927-33. PubMed ID: 24785575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyols as filler-binders for disintegrating tablets prepared by direct compaction.
    Bolhuis GK; Rexwinkel EG; Zuurman K
    Drug Dev Ind Pharm; 2009 Jun; 35(6):671-7. PubMed ID: 19274511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [On the compression behaviour of spray-dried sulphathiazole (author's transl)].
    Kala H; Moldenhauer H; Giese R; Kedvessy G; Selmeczi B; Pintye-Hódi K
    Pharmazie; 1982 Feb; 37(2):129-31. PubMed ID: 7071118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro release evaluation of hydrocortisone liquisolid tablets.
    Spireas S; Sadu S; Grover R
    J Pharm Sci; 1998 Jul; 87(7):867-72. PubMed ID: 9649356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: physicochemical and technological characterisation.
    Marinich JA; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2009 May; 72(1):138-47. PubMed ID: 19146956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclodextrin-containing poly(ethyleneoxide) tablets for the delivery of poorly soluble drugs: potential as buccal delivery system.
    Cappello B; De Rosa G; Giannini L; La Rotonda MI; Mensitieri G; Miro A; Quaglia F; Russo R
    Int J Pharm; 2006 Aug; 319(1-2):63-70. PubMed ID: 16650700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the physical properties of tablets and tablet excipients. VI. The application of accelerating test conditions to the study of water sorption and change in hardness.
    Nyqvist H; Lundgren P
    Acta Pharm Suec; 1982; 19(6):401-12. PubMed ID: 7164828
    [No Abstract]   [Full Text] [Related]  

  • 33. The wettability of powders during fluidized bed granulation [proceedings].
    Aulton ME; Banks M; Smith DK
    J Pharm Pharmacol; 1977 Dec; 29 Suppl():59P. PubMed ID: 22691
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of binders on anti hypertensive drugs.
    Agrawal YK; Majumdar F
    Boll Chim Farm; 1999 Nov; 138(10):531-43. PubMed ID: 10765470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmaceutical technology of Grandaxin].
    Fekete P
    Acta Pharm Hung; 1993 Mar; 63(2):67-78. PubMed ID: 8517166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of suitable amounts of water in fluidized bed granulation of pharmaceutical formulations using corresponding values of components.
    Miwa A; Yajima T; Ikuta H; Makado K
    Int J Pharm; 2008 Mar; 352(1-2):202-8. PubMed ID: 18160237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of excipients and formulation types on compressional properties of diclofenac.
    Ayorinde JO; Itiola AO; Odeniyi MA
    Acta Pol Pharm; 2013; 70(3):557-66. PubMed ID: 23757947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contact angles of pharmaceutical powders.
    Lerk CF; Lagas M; Boelstra JP; Broersma P
    J Pharm Sci; 1977 Oct; 66(10):1480-1. PubMed ID: 925908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [On the Polymorphism of barbiturates in powders and tablets. Part 4: the dissolution of barbital B and barbital A (modifications I and III and their release from tablets (author's transl)].
    Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1980 Jan; 35(1):32-5. PubMed ID: 7384174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of excipients and technological process on cholecalciferol stability and its liberation from tablets.
    Sawicka J
    Pharmazie; 1991 Jul; 46(7):519-21. PubMed ID: 1664519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.